# Ovarian Hyperstimulation Syndrome Using Calcium Infusion

> **NCT05198128** · NA · UNKNOWN · sponsor: **Al-Azhar University** · enrollment: 200 (estimated)

## Conditions studied

- Ovarian Hyperstimulation Syndrome

## Interventions

- **DRUG:** Calcium intravenous infsuion
- **DRUG:** 0.9 % saline

## Key facts

- **NCT ID:** NCT05198128
- **Lead sponsor:** Al-Azhar University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-01
- **Primary completion:** 2023-04-25
- **Final completion:** 2023-05-10
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2022-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05198128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05198128, "Ovarian Hyperstimulation Syndrome Using Calcium Infusion". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05198128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*